Literature DB >> 22020321

GREG cells, a dysferlin-deficient myogenic mouse cell line.

Glen W Humphrey1, Elena Mekhedov, Paul S Blank, Antoine de Morree, Gulcin Pekkurnaz, Kanneboyina Nagaraju, Joshua Zimmerberg.   

Abstract

The dysferlinopathies (e.g. LGMD2b, Myoshi myopathy) are progressive, adult-onset muscle wasting syndromes caused by mutations in the gene coding for dysferlin. Dysferlin is a large (~200kDa) membrane-anchored protein, required for maintenance of plasmalemmal integrity in muscle fibers. To facilitate analysis of dysferlin function in muscle cells, we have established a dysferlin-deficient myogenic cell line (GREG cells) from the A/J mouse, a genetic model for dysferlinopathy. GREG cells have no detectable dysferlin expression, but proliferate normally in growth medium and fuse into functional myotubes in differentiation medium. GREG myotubes exhibit deficiencies in plasma membrane repair, as measured by laser wounding in the presence of FM1-43 dye. Under the wounding conditions used, the majority (~66%) of GREG myotubes lack membrane repair capacity, while no membrane repair deficiency was observed in dysferlin-normal C2C12 myotubes, assayed under the same conditions. We discuss the possibility that the observed heterogeneity in membrane resealing represents genetic compensation for dysferlin deficiency. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020321      PMCID: PMC3541016          DOI: 10.1016/j.yexcr.2011.10.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  25 in total

Review 1.  Antigen retrieval in cells and tissues: enhancement with sodium dodecyl sulfate.

Authors:  J M Robinson; D D Vandré
Journal:  Histochem Cell Biol       Date:  2001-08       Impact factor: 4.304

2.  The endomembrane requirement for cell surface repair.

Authors:  Paul L McNeil; Katsuya Miyake; Steven S Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

3.  A quantitative procedure for the dissociation of adult mammalian muscle into mononucleated cells.

Authors:  R Yasin; G van Beers; D Bulien; E J Thompson
Journal:  Exp Cell Res       Date:  1976-10-15       Impact factor: 3.905

4.  The earliest pathologic alterations in dysferlinopathy.

Authors:  D Selcen; G Stilling; A G Engel
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

5.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.

Authors:  D Yaffe; O Saxel
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

6.  Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains.

Authors:  Dawn Belt Davis; Katherine R Doherty; Anthony J Delmonte; Elizabeth M McNally
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

7.  Defective membrane repair in dysferlin-deficient muscular dystrophy.

Authors:  Dimple Bansal; Katsuya Miyake; Steven S Vogel; Séverine Groh; Chien-Chang Chen; Roger Williamson; Paul L McNeil; Kevin P Campbell
Journal:  Nature       Date:  2003-05-08       Impact factor: 49.962

8.  Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Authors:  Mengfatt Ho; Cristina M Post; Leah R Donahue; Hart G W Lidov; Roderick T Bronson; Holly Goolsby; Simon C Watkins; Gregory A Cox; Robert H Brown
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

9.  Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing.

Authors:  Niall J Lennon; Alvin Kho; Brian J Bacskai; Sarah L Perlmutter; Bradley T Hyman; Robert H Brown
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

Review 10.  Dysferlin and the plasma membrane repair in muscular dystrophy.

Authors:  Dimple Bansal; Kevin P Campbell
Journal:  Trends Cell Biol       Date:  2004-04       Impact factor: 20.808

View more
  6 in total

1.  Dysferlin Binds SNAREs (Soluble N-Ethylmaleimide-sensitive Factor (NSF) Attachment Protein Receptors) and Stimulates Membrane Fusion in a Calcium-sensitive Manner.

Authors:  Sara J Codding; Naomi Marty; Nazish Abdullah; Colin P Johnson
Journal:  J Biol Chem       Date:  2016-05-10       Impact factor: 5.157

2.  Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy.

Authors:  Susanne Philippi; Anne Bigot; Andreas Marg; Vincent Mouly; Simone Spuler; Ute Zacharias
Journal:  PLoS Curr       Date:  2012-02-02

3.  Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.

Authors:  William Lostal; Marc Bartoli; Carinne Roudaut; Nathalie Bourg; Martin Krahn; Marina Pryadkina; Perrine Borel; Laurence Suel; Joseph A Roche; Daniel Stockholm; Robert J Bloch; Nicolas Levy; Rumaisa Bashir; Isabelle Richard
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

Review 4.  Functions of Vertebrate Ferlins.

Authors:  Anna V Bulankina; Sven Thoms
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

5.  4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations.

Authors:  Kana Tominaga; Naoomi Tominaga; Eric O Williams; Laura Rufibach; Verena Schöwel; Simone Spuler; Mohan Viswanathan; Leonard P Guarente
Journal:  iScience       Date:  2021-12-20

6.  Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion.

Authors:  A Defour; J H Van der Meulen; R Bhat; A Bigot; R Bashir; K Nagaraju; J K Jaiswal
Journal:  Cell Death Dis       Date:  2014-06-26       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.